Among some historical changes in prostate cancer diagnosis and management in the period of our study, as described in recent populational studies, the USPSTF recommendation coincided with worse outcomes of prostate cancer treatment in a population who could benefit from PSA screening at the appropriate time. Here, KLK3 is linked to prostate carcinoma.